Emerging pathogenic links between microbiota and the gut-lung axis

Nature Reviews Microbiology

Volumn 15, Issue 1, 2017, Pages 55-63

  Budden, Kurtis F ^a   Gellatly, Shaan L ^a   Wood, David L A ^b   Cooper, Matthew A ^b   Morrison, Mark ^b   Hugenholtz, Philip ^b   Hansbro, Philip M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; DYSBIOSIS; GUT LUNG AXIS; HUMAN; IMMUNITY; INTESTINE FLORA; LUNG; META ANALYSIS (TOPIC); METABOLITE; MICROBIAL METABOLISM; MICROFLORA; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; BACTERIUM; CLASSIFICATION; GASTROINTESTINAL TRACT; LUNG DISEASE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; LUNG; LUNG DISEASES; RESPIRATORY TRACT INFECTIONS;

EID: 84989950823     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.142     Document Type: Review

References (131)

1. Roussos, A., Koursarakos, P., Patsopoulos, D., Gerogianni, I. & Philippou, N. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir. Med. 97, 75-79 (2003).
2. Rutten, E. P., Lenaerts, K., Buurman, W. A. & Wouters, E. F. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 145, 245-252 (2014).
3. Yazar, A. et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am. J. Gastroenterol. 96, 1511-1516 (2001).
4. Keely, S., Talley, N. J. & Hansbro, P. M. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 5, 7-18 (2012).
5. Vieira, W. A. & Pretorius, E. The impact of asthma on the gastrointestinal tract (GIT). J. Asthma Allergy 3, 123-130 (2010).
6. Wymore Brand, M. et al. The altered Schaedler flora: continued applications of a defined murine microbial community. ILAR J. 56, 169-178 (2015).
7. Al-Asmakh, M. & Zadjali, F. Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583-1588 (2015).
8. Quercia, S. et al. From lifetime to evolution: timescales of human gut microbiota adaptation. Front. Microbiol. 5, 587 (2014).
9. Noverr, M. C., Falkowski, N. R., McDonald, R. A., McKenzie, A. N. & Huffnagle, G. B. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73, 30-38 (2005).
10. Russell, S. L. et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13, 440-447 (2012).
11. Russell, S. L. et al. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J. Allergy Clin. Immunol. 135, 100-109 (2015).
12. Arrieta, M. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 7, 307ra152 (2015).
13. Aguirre de Carcer, D. et al. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J. 5, 801-809 (2011).
14. Donaldson, G. P., Lee, S. M. & Mazmanian, S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20-32 (2016).
15. Buffie, C. G. & Pamer, E. G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790-801 (2013).
16. Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565-569 (2016).
17. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
18. Ormerod, K. L. et al. Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals. Microbiome 4, 36 (2016).
19. Morris, A. et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187, 1067-1075 (2013).
20. Bassis, C. M. et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 6, e00037 (2015).
21. H17 phenotype. Nat. Microbiol. 1, 16031 (2016).
22. Rogers, G. B. et al. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn. Microbiol. Infect. Dis. 62, 133-141 (2008).
23. Shanahan, E. R., Zhong, L., Talley, N. J., Morrison, M. & Holtmann, G. Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures. Aliment. Pharmacol. Ther. 43, 1186-1196 (2016).
24. Pope, P. B. et al. Isolation of Succinivibrionaceae implicated in low methane emissions from Tammar wallabies. Science 333, 646-648 (2011).
25. Neish, A. S. et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289, 1560-1563 (2000).
26. reg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
27. Ratner, A. J., Lysenko, E. S., Paul, M. N. & Weiser, J. N. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl Acad. Sci. USA 102, 3429-3434 (2005).
28. Preston, J. A. et al. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 25, 8154-8162 (2007).
29. Thorburn, A. N., Foster, P. S., Gibson, P. G. & Hansbro, P. M. Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. J. Immunol. 188, 4611-4620 (2012).
30. Thorburn, A. N. & Hansbro, P. M. Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am. J. Respir. Cell Mol. Biol. 43, 511-519 (2010).
31. Preston, J. A. et al. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur. Respir. J. 37, 53-64 (2011).
32. Bernasconi, E. et al. Airway microbiota determines innate cell inflammatory or tissue remodeling profiles in lung transplantation. Am. J. Respir. Crit. Care Med. http://dx.doi.org/10.1164/rccm.201512-2424OC (2016).
33. Larsen, J. M. et al. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology 144, 333-342 (2015).
34. Schuijt, T. J. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65, 575-583 (2016).
35. Dickson, R. P. & Cox, M. J. The premature invocation of a 'gut-lung axis' may obscure the direct effects of respiratory microbiota on pneumonia susceptibility. Gut http://dx.doi.org/10.1136/gutjnl-2016-311823 (2016).
36. van Nimwegen, F. A. et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J. Allergy Clin. Immunol. 128, 948-955 (2011).
37. Akay, H. K. et al. The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: a prospective study of 0-3 years-old children in Turkey. Anaerobe 28, 98-103 (2014).
38. Marsland, B. J., Trompette, A. & Gollwitzer, E. S. The gut-lung axis in respiratory disease. Ann. Am. Thorac. Soc. 12 (Suppl. 2), S150-S156 (2015).
39. Trompette, A. et al. Gut microbiota metabolism of dietary fibre influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166 (2014).
40. Dickson, R. P. et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat. Microbiol. 1, 16113 (2016).
41. Fagundes, C. T. et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J. Immunol. 188, 1411-1420 (2012).
42. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
43. Gauguet, S. et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 83, 4003-4014 (2015).
44. Fujimura, K. E. et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc. Natl Acad. Sci. USA 111, 805-810 (2014).
45. Samuelson, D. R., Welsh, D. A. & Shellito, J. E. Regulation of lung immunity and host defense by the intestinal microbiota. Front. Microbiol. 6, 1085 (2015).
46. Chen, Y. & Blaser, M. J. Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 167, 821-827 (2007).
47. Reibman, J. et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS ONE 3, e4060 (2008).
48. Chen, Y. & Blaser, M. J. Helicobacter pylori colonization is inversely associated with childhood asthma. J. Infect. Dis. 198, 553-560 (2008).
49. Wang, F., Liu, J., Zhang, Y. & Lei, P. Association of Helicobacter pylori infection with chronic obstructive pulmonary disease and chronic bronchitis: a meta-analysis of 16 studies. Infect. Dis. (Lond.) 47, 597-603 (2015).
50. Hussain, K. et al. Helicobacter pylori-mediated protection from allergy is associated with IL-10-secreting peripheral blood regulatory T cells. Front. Immunol. 7, 71 (2016).
51. McGhee, J. R. et al. Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS. J. Immunol. 124, 1603-1611 (1980).
52. Michalek, S. M., Kiyono, H., Wannemuehler, M. J., Mosteller, L. M. & McGhee, J. R. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J. Immunol. 128, 1992-1998 (1982).
53. Ueda, Y. et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int. Immunol. 22, 953-962 (2010).
54. Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
55. Sharon, G. et al. Specialized metabolites from the microbiome in health and disease. Cell Metab. 20, 719-730 (2014).
56. den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325-2340 (2013).
57. Thorburn, A. N. et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 6, 7320 (2015).
58. Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842-853 (2016).
59. Abrahamsson, T. R. et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44, 842-850 (2014).
60. Vael, C., Nelen, V., Verhulst, S. L., Goossens, H. & Desager, K. N. Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulm. Med. 8, 19 (2008).
61. Orivuori, L. et al. High level of faecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin. Exp. Allergy 45, 928-939 (2015).
62. Russell, S. L. et al. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4, 158-164 (2013).
63. Hevia, A. et al. Allergic patients with long-term asthma display low levels of Bifidobacterium adolescentis. PLoS ONE 11, e0147809 (2016).
64. Hua, X., Goedert, J. J., Pu, A., Yu, G. & Shi, J. Allergy associations with the adult fecal microbiota: analysis of the American Gut Project. EBioMedicine 3, 172-179 (2016).
65. He, F. et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol. 46, 781-785 (2002).
66. Johnson, J. L., Jones, M. B. & Cobb, B. A. Bacterial capsular polysaccharide prevents the onset of asthma through T cell activation. Glycobiology 25, 368-375 (2015).
67. reg modulator suppressing allergic asthma. Front. Microbiol. 6, 493 (2015).
68. Koch, K. N. et al. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J. Clin. Invest. 125, 3297-3302 (2015).
69. Engler, D. B. et al. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc. Natl Acad. Sci. USA 111, 11810-11815 (2014).
70. Kim, Y. G. et al. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host Microbe 15, 95-102 (2014).
71. Zaiss, M. M. et al. The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation. Immunity 45, 998-1010 (2015).
72. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
73. Huang, F. et al. Early-life exposure to Clostridium leptum causes pulmonary immunosuppression. PLoS ONE 10, e0141717 (2015).
74. Li, Y. N. et al. Effect of oral feeding with Clostridium leptum on regulatory T-cell responses and allergic airway inflammation in mice. Ann. Allergy Asthma Immunol. 109, 201-207 (2012).
75. Segal, L. N. et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1, 19 (2013).
76. Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. & Isaacson, R. E. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE 7, e47305 (2012).
77. Sze, M. A. et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185, 1073-1080 (2012).
78. Benjamin, J. L. et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm. Bowel Dis. 18, 1092-1100 (2012).
79. Biedermann, L. et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples. Inflamm. Bowel Dis. 20, 1496-1501 (2014).
80. Kabeerdoss, J., Jayakanthan, P., Pugazhendhi, S. & Ramakrishna, B. S. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J. Med. Res. 142, 23-32 (2015).
81. Schwab, C. et al. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 8, 1101-1114 (2014).
82. Khonsari, S. et al. A comparative study of bifidobacteria in human babies and adults. Biosci. Microbiota Food Health 35, 97-103 (2016).
83. Verschuere, S. et al. Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab. Invest. 91, 1056-1067 (2011).
84. Allais, L. et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ. Microbiol. 18, 1352-1363 (2015).
85. Hammadi, M., Adi, M., John, R., Khoder, G. A. & Karam, S. M. Dysregulation of gastric H, K-ATPase by cigarette smoke extract. World J. Gastroenterol. 15, 4016-4022 (2009).
86. Sapkota, A. R., Berger, S. & Vogel, T. M. Human pathogens abundant in the bacterial metagenome of cigarettes. Environ. Health Perspect. 118, 351-356 (2010).
87. Kulkarni, R. et al. Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. Intect Immun. 80, 3804-3811 (2012).
88. Semlali, A., Killer, K., Alanazi, H., Chmielewski, W. & Rouabhia, M. Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression. BMC Microbiol. 14, 61 (2014).
89. Hu, J., Wei, T., Sun, S., Zhao, A. & Xu, C. Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium. An. Acad. Bras. Cienc. 87, 997-1005 (2015).
90. Reale, M. et al. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. Br. J. Nutr. 108, 308-314 (2012).
91. Verheijden, K. A. T. et al. Treatment with specific prebiotics or probiotics prevents the development of lung emphysema in a mouse model of COPD. Eur. J. Pharmacol. 668, e12-e13 (2011).
92. Mortaz, E. et al. Anti-inflammatory effects of Lactobacillus rahmnosus and Bifidobacterium breve on cigarette smoke activated human macrophages. PLoS ONE 10, e0136455 (2015).
93. Tomoda, K. et al. Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice. BMC Pulm. Med. 15, 64 (2015).
94. Tomoda, K. et al. Cigarette smoke decreases organic acids levels and population of Bifidobacterium in caecum of rats. J. Toxicol. Sci. 36, 261-266 (2011).
95. Kish, L. et al. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS ONE 8, e62220 (2013).
96. Zuo, L. et al. Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice. J. Crohns Colitis 8, 1710-1722 (2014).
97. Huvenne, W. et al. Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin in mice. Respir. Res. 12, 69 (2011).
98. Brass, D. M. et al. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am. J. Respir. Cell. Mol. Biol. 39, 584-590 (2008).
99. Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662-671 (2015).
100. Suzuki, T., Yoshida, S. & Hara, H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. B r. J. Nutr. 100, 297-305 (2008).
101. Chen, L. W., Chen, P. H. & Hsu, C. M. Commensal microflora contribute to host defense against Escherichia coli pneumonia through toll-like receptors. Shock 36, 67-75 (2011).
102. Ichinohe, T. et al. Microbiota regulates immune defence against respiratory tract influenza A virus infection. Proc. Natl Acad. Sci. USA 108, 5354-5359 (2011).
103. Wu, S. et al. Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection. Curr. Microbiol. 67, 414-422 (2013).
104. 1A. Microbes Infect. 18, 180-189 (2016).
105. Kawahara, T. et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol. Immunol. 59, 1-12 (2015).
106. Luoto, R. et al. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized placebo-controlled trial. J. Allergy Clin. Immunol. 133, 405-413 (2014).
107. Jespersen, L. et al. Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. Am. J. Clin. Nutr. 101, 1188-1196 (2015).
108. King, S., Glanville, J., Sanders, M. E., Fitzgerald, A. & Varley, D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br. J. Nutr. 112, 41-54 (2014).
109. West, N. P. et al. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin. Nutr. 33, 581-587 (2014).
110. Clarke, T. B. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via Nod-like receptor ligands. Infect. Immun. 82, 4596-4606 (2014).
111. Oh, K. Z. et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478-492 (2014).
112. Bernard, H. et al. Dietary pectin-derived acidic oligosaccharides improve the pulmonary bacterial clearance of Pseudomonas aeruginosa lung infection in mice by modulating intestinal microbiota and immunity. J. Infect. Dis. 2 11, 156-165 (2015).
113. Kishino, E., Takemura, N., Masaki, H., Ito, T. & Nakazawa, M. Dietary lactosucrose suppresses influenza A (H1N1) virus infection in mice. Biosci. Microbiota Food Health 34, 67-76 (2015).
114. H17 cell-dependent inflammation. J. Exp. Med. 211, 2397-2410 (2014).
115. Huang, Y. J. & LiPuma, J. J. The microbiome in cystic fibrosis. Clin. Chest Med. 37, 59-67 (2016).
116. Strachan, D. P. Hay fever, hygiene, and household size. BMJ 299, 1259-1260 (1989).
117. Riedler, J. et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358, 1129-1133 (2001).
118. Ball, T. M. et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N. Engl. J. Med. 343, 538-543 (2000).
119. Rook, G. A., Martinelli, R. & Brunet, L. R. Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr. Opin. Allergy Clin. Immunol. 3, 337-342 (2003).
120. Bieber, T. Atopic dermatitis. N. Engl. J. Med. 358, 1483-1494 (2008).
121. Gale, E. A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353-3361 (2002).
122. Alonso, A. & Hernan, M. A. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71, 129-135 (2008).
123. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
124. Ottman, N., Smidt, H., de Vos, W. M. & Belzer, C. The function of our microbiota: who is out there and what do they do? Front. Cell. Infect. Microbiol. 2, 104 (2012).
125. Okada, H., Kuhn, C., Feillet, H. & Bach, J. F. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 160, 1-9 (2010).
126. Maizels, R. M., McSorley, H. J. & Smyth, D. J. Helminths in the hygiene hypothesis: sooner or later? Clin. Exp. Immunol. 177, 38-46 (2014).
127. Sun, X., Fiala, J. L. & Lowery, D. Patent watch: modulating the human microbiome with live biotherapeutic products: intellectual property landscape. Nat. Rev. Drug Discov. 15, 224-225 (2016).
128. Brown, A. J. et al. Pharmacological properties of acid N-thiazolylamide FFA2 agonists. Pharmacol. Res. Perspect. 3, e00141 (2015).
129. Hudson, B. D. et al. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. J. Biol. Chem. 288, 17296-17312 (2013).
130. Schmidt, J. et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J. Biol. Chem. 286, 10628-10640 (2011).
131. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).